Amino.Desk

Dulaglutide (Trulicity)

Updated Nov 17, 2026 · Clinical review: pending

Dulaglutide is the weekly GLP-1 injection sold as Trulicity. It is approved for type 2 diabetes and is not approved for weight loss. People on it do lose some weight, but far less than on the drugs built for that purpose.

What it is

Dulaglutide is a GLP-1 medication first approved in the US in 2014. It belongs to the same family as semaglutide and liraglutide. It is prescribed to improve blood sugar in type 2 diabetes, and its label also covers lowering the risk of major heart events in adults with type 2 diabetes who have heart disease or several risk factors.

What the evidence shows

Its trials were diabetes trials. Weight was a secondary measure.

In the trial that tested the higher doses, AWARD-11, 1,842 adults with type 2 diabetes took 1.5 mg, 3 mg or 4.5 mg a week. At 36 weeks, average weight change was about 6.6 lb on 1.5 mg, 8.4 lb on 3 mg and 10.1 lb on 4.5 mg, from a starting weight near 210 lb. The manufacturer notes that some patients did not lose weight.

That is roughly 3% to 5% of body weight at the top doses, which is why dulaglutide is not marketed or approved as a weight-loss drug.

Legal status

Label dosing

The label starts at 0.75 mg once a week. The dose can be raised to 1.5 mg for more blood sugar control, and then in 1.5 mg steps after at least four weeks on the current dose, to a maximum of 4.5 mg once a week. These steps are set by blood sugar response, not weight. The dose on your prescription is the one to follow.

Safety

Common questions

Is Trulicity approved for weight loss?

No. It is approved for type 2 diabetes. Weight change was a secondary measure in its trials.

How much weight do people lose on Trulicity?

In the AWARD-11 trial, about 6.6 lb to 10.1 lb on average at 36 weeks, depending on dose, and some patients did not lose weight.

What are the Trulicity doses?

The label starts at 0.75 mg once a week and allows increases to 1.5 mg, 3 mg and a maximum of 4.5 mg.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy